Hasil Pencarian - Lydia Visser
- Menampilkan 1 - 20 hasil dari 29
- Ke Halaman Berikutnya
-
1
Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma oleh Lydia Visser, Rui Wu, Bea Rutgers, Arjan Diepstra, Anke van den Berg
Diterbitkan 2016-12-01
Artikel -
2
-
3
-
4
The Microenvironment in Epstein–Barr Virus-Associated Malignancies oleh Geok Wee Tan, Lydia Visser, Lu Ping Tan, Anke van den Berg, Arjan Diepstra
Diterbitkan 2018-04-01
Artikel -
5
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma oleh Myra Langendonk, Nienke A. M. Smit, Wouter Plattel, Arjan Diepstra, Tom van Meerten, Lydia Visser
Diterbitkan 2022-11-01
Artikel -
6
-
7
-
8
Site-Directed Mutants of Parasporin PS2Aa1 with Enhanced Cytotoxic Activity in Colorectal Cancer Cell Lines oleh Miguel O. Suárez-Barrera, Lydia Visser, Efraín H. Pinzón-Reyes, Paola Rondón Villarreal, Juan S. Alarcón-Aldana, Nohora Juliana Rueda-Forero
Diterbitkan 2022-10-01
Artikel -
9
Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients. oleh Xin Huang, Anke van den Berg, Zifen Gao, Lydia Visser, Ilja Nolte, Hans Vos, Bouke Hepkema, Wierd Kooistra, Sibrand Poppema, Arjan Diepstra
Diterbitkan 2010-05-01
Artikel -
10
Toxic Determination of Cry11 Mutated Proteins Obtained Using Rational Design and Its Computational Analysis oleh Miguel O. Suárez-Barrera, Diego F. Herrera-Pineda, Paola Rondón-Villarreal, Efraín Hernando Pinzón-Reyes, Rodrigo Ochoa, Lydia Visser, Nohora Juliana Rueda-Forero
Diterbitkan 2023-05-01
Artikel -
11
HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy? oleh Marcel Nijland, Rianne N. Veenstra, Lydia Visser, Chuanhui Xu, Kushi Kushekhar, Gustaaf W. van Imhoff, Philip M. Kluin, Anke van den Berg, Arjan Diepstra
Diterbitkan 2017-04-01
Artikel -
12
HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in China. oleh Xin Huang, Bouke Hepkema, Ilja Nolte, Kushi Kushekhar, Theo Jongsma, Rianne Veenstra, Sibrand Poppema, Zifen Gao, Lydia Visser, Arjan Diepstra, Anke van den Berg
Diterbitkan 2012-01-01
Artikel -
13
WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma oleh Mathilde R. W. de Jong, Myra Langendonk, Bart Reitsma, Pien Herbers, Monique Lodewijk, Marcel Nijland, Anke van den Berg, Emanuele Ammatuna, Lydia Visser, Tom van Meerten
Diterbitkan 2020-01-01
Artikel -
14
Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin’s lymphoma oleh Wouter J. Plattel, Anke van den Berg, Lydia Visser, Anne-Marijn van der Graaf, Jan Pruim, Hans Vos, Bouke Hepkema, Arjan Diepstra, Gustaaf W. van Imhoff
Diterbitkan 2012-03-01
Artikel -
15
P031: CD4+ T cells in close proximity to Hodgkin-Reed Sternberg cells are antigen experienced, polyclonal and display an exhausted phenotype oleh Johanna Veldman, Jessica Rodrigues Plaça., Lauren Chong, Martijn Terpstra, Mirjam Mastik, Léon C. Van Kempen, Tomohiro Aoki, Christian Steidl, Anke Van Den Berg, Lydia Visser, Arjan Diepstra
Diterbitkan 2022-10-01
Artikel -
16
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro. oleh Marion M Malenge, Astri Fjelde Maaland, Ada Repetto-Llamazares, Brian Middleton, Marcel Nijland, Lydia Visser, Sebastian Patzke, Helen Heyerdahl, Arne Kolstad, Trond Stokke, Anne Hansen Ree, Jostein Dahle
Diterbitkan 2022-01-01
Artikel -
17
T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial oleh Arjan Diepstra, Lydia Visser, Catherine Fortpied, Walter Noordzij, Annika Loft, Anne Arens, Anna Sureda-Balari, Susana Carvalho, Andrej Vranovský, Ward Sents, Emanuel Buhrer, Wouter J. Plattel, Martin Hutchings
Diterbitkan 2022-10-01
Artikel -
18
Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity towards Multiple Anticancer Agents and Its Potential Interplay with the IGF-1R/Akt/p53 Signaling Path... oleh Hai-Ying Mo, Qi-Yao Wei, Qiu-Hua Zhong, Xiao-Yun Zhao, Dan Guo, Jin Han, Wachiraporn Noracharttiyapot, Lydia Visser, Anke van den Berg, Yan-Ming Xu, Andy T. Y. Lau
Diterbitkan 2022-07-01
Artikel -
19
CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma oleh Johanna Veldman, Jessica Rodrigues Plaça, Lauren Chong, Miente Martijn Terpstra, Mirjam Mastik, Léon C. van Kempen, Klaas Kok, Tomohiro Aoki, Christian Steidl, Anke van den Berg, Lydia Visser, Arjan Diepstra
Diterbitkan 2022-12-01
Artikel -
20
HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients. oleh Luke B Fletcher, Rianne N Veenstra, Eric Y Loo, Amie E Hwang, Imran N Siddiqi, Lydia Visser, Bouke G Hepkema, Ilja M Nolte, Anke van den Berg, Wendy Cozen, Arjan Diepstra
Diterbitkan 2017-01-01
Artikel